Close Menu
    Facebook X (Twitter) Instagram
    Trending
    • The Employee Who Never Sleeps: Why Meta’s New Business Agent Signals A Much Bigger Shift In Work
    • Verma Family Welcomes a Baby Boy on Dr. Abhishek Verma and Mrs. Anca Verma’s Wedding Anniversary
    • Leica expands camera colour palette with Metal Gray finish added to the lineup
    • VAHH Chemicals Limited’s Initial Public Offering Opens on June 4 to June 8, 2026 with Price Fixed at Rs.60 Per Share
    • eYantra Ventures Limited Reports FY26 Annual Results
    • VMS TMT Limited Announces Q4 FY26 and FY26 Results
    • PPMS Group Joins with Prashant Janadri for Activatr – Distribution Platform for Consumer Brands
    • UMC Hospitals, Navi Mumbai Successfully Performs Its First Robotic Surgery
    Republic News Today
    • Business
    • Entertainment
    • Lifestyle
    • National
    • Technology
    • Education
    Republic News Today
    Home»Health»Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD
    Health

    Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

    By December 16, 2022No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Reddit WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest WhatsApp Email
    Read Time:1 Minute, 21 Second

    Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

    New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

    Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

    Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

    If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

    About Post Author


    RNT Reporter


    dhaval.rntoday@gmail.com

    https://republicnewstoday.com

    The post Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD appeared first on Republic News Today.

    Healthcare

    Related Posts

    Dr. Rohit Yadav — Among Delhi NCR’s Most Recognised Corticobasal® Implantologists, with 14+ Years of Experience and 25,000+ Corticobasal® Implants Placed

    June 2, 2026

    Diagnoses, Tips and Care for Dengue amid Monsoon Surge

    June 1, 2026

    Ashwagandha Industry Calls for Science-Led Review to Protect Farmers, Ayurveda, and India’s Nutraceutical Growth

    May 22, 2026

    Comments are closed.

    Recent Posts
    • The Employee Who Never Sleeps: Why Meta’s New Business Agent Signals A Much Bigger Shift In Work
    • Verma Family Welcomes a Baby Boy on Dr. Abhishek Verma and Mrs. Anca Verma’s Wedding Anniversary
    • Leica expands camera colour palette with Metal Gray finish added to the lineup
    • VAHH Chemicals Limited’s Initial Public Offering Opens on June 4 to June 8, 2026 with Price Fixed at Rs.60 Per Share
    • eYantra Ventures Limited Reports FY26 Annual Results
    Search
    Recent Posts
    • The Employee Who Never Sleeps: Why Meta’s New Business Agent Signals A Much Bigger Shift In Work
    • Verma Family Welcomes a Baby Boy on Dr. Abhishek Verma and Mrs. Anca Verma’s Wedding Anniversary
    • Leica expands camera colour palette with Metal Gray finish added to the lineup
    • VAHH Chemicals Limited’s Initial Public Offering Opens on June 4 to June 8, 2026 with Price Fixed at Rs.60 Per Share
    • eYantra Ventures Limited Reports FY26 Annual Results
    • VMS TMT Limited Announces Q4 FY26 and FY26 Results

    Type above and press Enter to search. Press Esc to cancel.